Molecular Pathogenesis of Endometrial and Ovarian Cancer

作者: Melissa A. Merritt , Daniel W. Cramer

DOI: 10.3233/CBM-2011-0167

关键词:

摘要: Pregnancy, breastfeeding, and oral contraceptive pill use interrupt menstrual cycles reduce endometrial ovarian cancer risk. This suggests the importance of turnover within Mullerian tissues, where accumulation mutations in p53 PTEN has been correlated with number cycles. The most common type (Type I) is endometrioid molecular abnormalities include PTEN, KRAS β-catenin. Type I precursor Endometrial Intraepithelial Neoplasia which displays defects. II (whose precursors are less clear) includes serous clear cell tumors alteration mutation. For cancer, histopathologic types parallel serous, mucinous, endometrioid, cell; some features also shared. frequent high grade that often mutation its lesions may originate from normal-appearing fallopian tube epithelium contains a "signature". Mutations KRAS, BRAF described low cancers these cortical inclusion cysts. A consideration other pathogenetic features, like epidemiology histopathology, provide better understanding cancer.

参考文章(188)
Jeffrey S. Ross, Fan Yang, Bhaskar V. S. Kallakury, Christine E. Sheehan, Robert A. Ambros, Patrick J. Muraca, HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary. American Journal of Clinical Pathology. ,vol. 111, pp. 311- 316 ,(1999) , 10.1093/AJCP/111.3.311
Michael Huncharek, Bruce Kupelnick, J F Geschwind, Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: A meta-analysis of 11, 933 subjects from sixteen observational studies Anticancer Research. ,vol. 23, pp. 1955- 1960 ,(2003)
Mats Lambe, Joanne Wuu, Elisabete Weiderpass, Chung-Cheng Hsieh, Childbearing at older age and endometrial cancer risk (Sweden). Cancer Causes & Control. ,vol. 10, pp. 43- 49 ,(1999) , 10.1023/A:1008860615584
K R Cho, T D Kessis, L Hedrick, R T Burks, Microsatellite instability in endometrial carcinoma. Oncogene. ,vol. 9, pp. 1163- 1166 ,(1994)
Carlo La Vecchia, Oral contraceptives and ovarian cancer: an update 1998-2004. European Journal of Cancer Prevention. ,vol. 15, pp. 117- 124 ,(2006) , 10.1097/01.CEJ.0000179274.24200.9D
Georgia Chenevix-Trench, Andrew Hitchcock, Eric J. Thomas, Sarah J. Morland, Ian G. Campbell, Richard H. Watson, Koshiro Obata, Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Research. ,vol. 58, pp. 2095- 2097 ,(1998)
Vuk Stambolic, David Macpherson, William B. Chapman, Ming-Sound Tsao, Akira Suzuki, Tak W. Mak, High Incidence of Breast and Endometrial Neoplasia Resembling Human Cowden Syndrome in pten+/− Mice Cancer Research. ,vol. 60, pp. 3605- 3611 ,(2000)
Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein, Genetic instabilities in human cancers Nature. ,vol. 396, pp. 643- 649 ,(1998) , 10.1038/25292
Hannah Kuper, Daniel W. Cramer, Linda Titus‐Ernstoff, Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes & Control. ,vol. 13, pp. 455- 463 ,(2002) , 10.1023/A:1015751105039
Miriam Cuatrecasas, Alberto Villanueva, Xavier Matias‐Guiu, Jaime Prat, None, K-ras mutations in mucinous ovarian tumors : A clinicopathologic and molecular study of 95 cases Cancer. ,vol. 79, pp. 1581- 1586 ,(1997) , 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T